Table 2 Response to treatment/efficacy endpoints
Endpoints | Results |
|---|---|
Response n (%) | |
Complete response (CR) | 5 (14.3) |
Partial response (PR) | 7 (20.0) |
Stable disease (SD) | 4 (11.4) |
Progressive disease (PD) | 19 (54.3) |
Overall response rate [ORR (CR + PR)] | 12 (34.3) |
Disease control rate [DCR (CR + PR + SD)] | 16 (45.7) |
PD-1 + chemotherapy | 14 (50.0) |
PD-1 alone | 2 (28.6) |
12-month overall survival rate % (SE) | 68.5 (8.9) |
24-month overall survival rate % (SE) | 27.4 (10.3) |